408 related articles for article (PubMed ID: 34452630)
1. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application.
Hu C; Liu X; Zeng Y; Liu J; Wu F
Clin Epigenetics; 2021 Aug; 13(1):166. PubMed ID: 34452630
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
Lyko F; Brown R
J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
[TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase inhibitors for cancer therapy.
Brueckner B; Kuck D; Lyko F
Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
5. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic-based therapies in cancer: progress to date.
Song SH; Han SW; Bang YJ
Drugs; 2011 Dec; 71(18):2391-403. PubMed ID: 22141383
[TBL] [Abstract][Full Text] [Related]
7. Dual targeting of epigenetic therapy in cancer.
Hellebrekers DM; Griffioen AW; van Engeland M
Biochim Biophys Acta; 2007 Jan; 1775(1):76-91. PubMed ID: 16930846
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies.
Fahy J; Jeltsch A; Arimondo PB
Expert Opin Ther Pat; 2012 Dec; 22(12):1427-42. PubMed ID: 23033952
[TBL] [Abstract][Full Text] [Related]
10. Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy.
Mazzone R; Zwergel C; Mai A; Valente S
Clin Epigenetics; 2017; 9():59. PubMed ID: 28572863
[TBL] [Abstract][Full Text] [Related]
11. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of epigenetically silenced genes by DNA methyltransferase inhibitors: basic concepts and clinical applications.
Mund C; Brueckner B; Lyko F
Epigenetics; 2006; 1(1):7-13. PubMed ID: 17998812
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and cancer.
Gokul G; Khosla S
Subcell Biochem; 2013; 61():597-625. PubMed ID: 23150269
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation as a chemotherapy target.
Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
[TBL] [Abstract][Full Text] [Related]
15. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors.
Yang AS; Yang BJ
Epigenomics; 2016 Jan; 8(1):9-12. PubMed ID: 26698294
[No Abstract] [Full Text] [Related]
16. Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.
Gravina GL; Festuccia C; Marampon F; Popov VM; Pestell RG; Zani BM; Tombolini V
Mol Cancer; 2010 Nov; 9():305. PubMed ID: 21108789
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic drug discovery: targeting DNA methyltransferases.
Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapies reach main street.
Bates SE
Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
[No Abstract] [Full Text] [Related]
19. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
Stresemann C; Lyko F
Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics in radiotherapy: where are we heading?
Smits KM; Melotte V; Niessen HE; Dubois L; Oberije C; Troost EG; Starmans MH; Boutros PC; Vooijs M; van Engeland M; Lambin P
Radiother Oncol; 2014 May; 111(2):168-77. PubMed ID: 24861629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
